Establishment of a Registry of Patients With Parathyroid Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-03

Study Completion Date

2039-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Establishment of a registry with which to census all patients under the care of the O.U. Endocrinology for parathyroid pathology in order to longitudinally evaluate biochemical, clinical, radiological, medico-nuclear and histological data in future studies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma

NCT06645951

Parathyroid Gland Carcinoma Parathyroid Gland Atypical Adenoma

RECRUITING

A Registry for Participants With Chronic Hypoparathyroidism

NCT01922440

Hypoparathyroidism

ACTIVE_NOT_RECRUITING

Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism

NCT06445036

Hypoparathyroidism Pseudo Hypoparathyroidism

NOT_YET_RECRUITING

Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer

NCT06627998

Cancer of Thyroid Vertebral Fracture Osteoporosis

RECRUITING

Studies of Elevated Parathyroid Activity

NCT00001277

Hyperparathyroidism Hypercalcemia Parathyroid Neoplasm +2 more

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Inclusion in the registry will be offered consecutively to any patient with parathyroid pathology (hyperparathyroidism or hypoparathyroidism) diagnosed and evaluated at the Endocrinology Operating Unit through at least two endocrinology visits. The registry will include patients seen from 1/1/2000 for a duration of 30 years. Follow-up duration for each patient is expected to be 10 years, with enrollment until 12/31/2029, and registry update deadline on 12/31/2039.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperparathyroidism Hypoparathyroidism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years
* Diagnosis of hyperparathyroidism or hypoparathyroidism based on biochemical parameters (calcemia, parathormone, phosphormia, creatinine, albumin, vitamin D25OH)
* Obtaining informed consent